MFN2 and lung carcinoma: In lung cancer, MFN2 has also been demonstrated to inhibit Rictor, a subunit of the mTORC2 complex, which prevents AKT1 phosphorylation and subsequent cytoskeletal reorganization for cell division (Xu et al., 2017).